Christopher Zosh
Director of Finance/CFO bei STATERA BIOPHARMA, INC.
Profil
Christopher Zosh is currently the Director at Panacela Labs, Inc. since 2017 and the VP, Chief Financial & Accounting Officer at Statera Biopharma, Inc. since 2014.
Previously, he worked at Cleveland BioLabs, Inc. as the CAO, Chief Executive & Financial Officer from 2019 to 2021.
Mr. Zosh completed his undergraduate degree at the State University of New York at Buffalo.
Aktive Positionen von Christopher Zosh
Unternehmen | Position | Beginn |
---|---|---|
STATERA BIOPHARMA, INC. | Director of Finance/CFO | 27.05.2022 |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Director/Board Member | 01.07.2017 |
Ehemalige bekannte Positionen von Christopher Zosh
Unternehmen | Position | Ende |
---|---|---|
STATERA BIOPHARMA, INC. | Chief Executive Officer | 27.07.2021 |
Ausbildung von Christopher Zosh
State University of New York at Buffalo | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
STATERA BIOPHARMA, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Cleveland BioLabs, Inc.
Cleveland BioLabs, Inc. Pharmaceuticals: MajorHealth Technology Cleveland BioLabs, Inc. operates as a biopharmaceutical company, which engages in the research and development of drugs. It focuses on oncology and acute radiation syndrome. It offers Entolimod, Mobilan, CBL0137, and SA-702. The company was founded by Andrei V. Gudkov and Yakov Kogan on June 5, 2003 and is headquartered in Buffalo, NY. | Health Technology |
Panacela Labs, Inc.
Panacela Labs, Inc. Pharmaceuticals: MajorHealth Technology Panacela Labs, Inc. specializes in oncology and orphan drug development. It operates as a clinical stage biotech firm that develops anticancer drug products. The firm provides its Mobilan drug for prostate cancer therapy. The company was founded in 2011 and is headquartered in Buffalo, NY. | Health Technology |